A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group - PubMed (original) (raw)

Clinical Trial

A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group

W H Allum et al. Br J Cancer. 1989 Nov.

Free PMC article

Abstract

A prospective, randomised controlled trial of surgery, surgery with adjuvant radiotherapy and surgery with adjuvant chemotherapy (5-fluorouracil, adriamycin and mitomycin C) in operable gastric cancer is described. Four hundred and thirty-six patients were randomly allocated to one of three treatment groups. With 12 months' minimum follow-up, 334 patients have died, 292 from recurrent cancer. The median survival for all patients was 15 months. Neither form of adjuvant therapy provides any survival advantage. Surgery remains the principal treatment for operable gastric cancer. Care should be taken to standardise surgical treatment and any adjuvant treatments must be compared within the confines of controlled, randomised trials.

PubMed Disclaimer

Similar articles

• The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up.
  Hallissey MT, Dunn JA, Ward LC, Allum WH. Hallissey MT, et al. Lancet. 1994 May 28;343(8909):1309-12. doi: 10.1016/s0140-6736(94)92464-3. Lancet. 1994. PMID: 7910321 Clinical Trial.
• A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.
  Coombes RC, Schein PS, Chilvers CE, Wils J, Beretta G, Bliss JM, Rutten A, Amadori D, Cortes-Funes H, Villar-Grimalt A, et al. Coombes RC, et al. J Clin Oncol. 1990 Aug;8(8):1362-9. doi: 10.1200/JCO.1990.8.8.1362. J Clin Oncol. 1990. PMID: 2199622 Clinical Trial.
• Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
  Lise M, Nitti D, Buyse M, Cartei G, Fornasiero A, Guimaraes dos Santos J, Duez N. Lise M, et al. Recent Results Cancer Res. 1988;110:36-43. doi: 10.1007/978-3-642-83293-2_5. Recent Results Cancer Res. 1988. PMID: 3043595 Clinical Trial. No abstract available.
• Chemotherapy of gastric cancer: a review.
  Kelsen D. Kelsen D. Isr J Med Sci. 1988 Sep-Oct;24(9-10):557-61. Isr J Med Sci. 1988. PMID: 3060446 Review.
• [Present status of surgical adjuvant chemotherapy of gastric cancer].
  Taguchi T. Taguchi T. Gan To Kagaku Ryoho. 1989 Jun;16(6):2169-72. Gan To Kagaku Ryoho. 1989. PMID: 2500066 Review. Japanese.

Cited by

• Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer.
  Giuliani A, Miccini M, Basso L. Giuliani A, et al. World J Gastroenterol. 2014 Apr 14;20(14):3889-904. doi: 10.3748/wjg.v20.i14.3889. World J Gastroenterol. 2014. PMID: 24744579 Free PMC article. Review.
• Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view.
  Lim DH, Kim DY, Kang MK, Kim YI, Kang WK, Park CK, Kim S, Noh JH, Joh JW, Choi SH, Sohn TS, Heo JS, Park CH, Park JO, Lee JE, Park YJ, Nam HR, Park W, Ahn YC, Huh SJ. Lim DH, et al. Br J Cancer. 2004 Jul 5;91(1):11-7. doi: 10.1038/sj.bjc.6601896. Br J Cancer. 2004. PMID: 15162146 Free PMC article. Clinical Trial.
• Effects of dna-dependent protein kinase inhibition by NU7026 on dna repair and cell survival in irradiated gastric cancer cell line N87.
  Niazi MT, Mok G, Heravi M, Lee L, Vuong T, Aloyz R, Panasci L, Muanza T. Niazi MT, et al. Curr Oncol. 2014 Apr;21(2):91-6. doi: 10.3747/co.21.1509. Curr Oncol. 2014. PMID: 24764698 Free PMC article.
• Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy.
  Ajani JA, Mansfield PF, Ota DM. Ajani JA, et al. World J Surg. 1995 Mar-Apr;19(2):216-20. doi: 10.1007/BF00308629. World J Surg. 1995. PMID: 7754626 Review.
• Preoperative chemoradiotherapy for locally advanced gastric cancer.
  Pepek JM, Chino JP, Willett CG, Palta M, Blazer Iii DG, Tyler DS, Uronis HE, Czito BG. Pepek JM, et al. Radiat Oncol. 2013 Jan 4;8:6. doi: 10.1186/1748-717X-8-6. Radiat Oncol. 2013. PMID: 23286735 Free PMC article.

References

1. 1. Strahlentherapie. 1970 Jul;140(1):20-6 - PubMed
2. 1. World J Surg. 1977 Mar;2(1):213-21 - PubMed
3. 1. Recent Results Cancer Res. 1977;(62):177-80 - PubMed
4. 1. Int J Clin Pharmacol Biopharm. 1978 May;16(5):209-16 - PubMed
5. 1. Cancer. 1978 Jun;41(6):2088-98 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central

• Medical

  • MedlinePlus Health Information